Literature DB >> 17264349

Radiation therapy for ductal carcinoma in situ: is it really worth it?

Mangesh A Thorat, Vani Parmar, Mandar S Nadkarni, Rajendra A Badwe.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17264349     DOI： 10.1200/JCO.2006.09.1645

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  A Molecular Portrait of High-Grade Ductal Carcinoma In Situ.

Authors:  Martin C Abba; Ting Gong; Yue Lu; Jaeho Lee; Yi Zhong; Ezequiel Lacunza; Matias Butti; Yoko Takata; Sally Gaddis; Jianjun Shen; Marcos R Estecio; Aysegul A Sahin; C Marcelo Aldaz
Journal:  Cancer Res       Date:  2015-08-06       Impact factor: 12.701

2.  TBX3 promotes progression of pre-invasive breast cancer cells by inducing EMT and directly up-regulating SLUG.

Authors:  Milica Krstic; Bart Kolendowski; Matthew J Cecchini; Carl O Postenka; Haider M Hassan; Joseph Andrews; Connor D MacMillan; Karla C Williams; Hon S Leong; Muriel Brackstone; Joseph Torchia; Ann F Chambers; Alan B Tuck
Journal:  J Pathol       Date:  2019-04-08       Impact factor: 7.996

3.  The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ.

Authors:  Onur Gilleard; Andrew Goodman; Martin Cooper; Mary Davies; Julie Dunn
Journal:  World J Surg Oncol       Date:  2008-06-18       Impact factor: 2.754
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.